Quick Search 
Drugs of the Future
Register or sign in

  
 
  
Volume 43, Issue 1, January 2018, Pages 5-81
 
MONOGRAPHS
 
  
 Savolitinib.
Hepatocyte growth factor receptor (HGFR, MET, c-Met) inhibitor, Cancer therapy.
Gras, J.
Drugs Fut 2018, 43(1): 5
Summary | Full Text: PDF 
 
  
  
 TAS-116.
Second-generation HSP90-α/β inhibitor, Cancer therapy.
Suzuki, R., Hidehsima, T., Anderson, K.C.
Drugs Fut 2018, 43(1): 13
Summary | Full Text: PDF 
 
  
 
REVIEW ARTICLE
 
  
 Prolyl hydroxylase inhibitors for the treatment of anemia in chronic kidney disease.
Cases, A., Vera, M., Ojeda, R., Gorriz, J.L.
Drugs Fut 2018, 43(1): 23
Summary | Full Text: PDF 
 
  
 
DRUGLINE
 
  
 Pipeline on the move.
Torramade, E., Gonzalez Brao, M.M., Mila, M.
Drugs Fut 2018, 43(1): 35
Full Text: PDF 
 
  
  
 NME Digest.
Bofill, X., Cole, P., Fernandez-Forner, D., Torramade, E.
Drugs Fut 2018, 43(1): 51
Full Text: PDF 
 
  
 
MEETING REPORT
 
  
 36th Annual J.P. Morgan Healthcare Conference. San Francisco, California, USA – January 8-11, 2018.
Croasdell, G., Sharman, R., Watt, J.
Drugs Fut 2018, 43(1): 67
Summary | Full Text: PDF 
 
  
 
  



© 2022 Clarivate. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie PolicyManage cookie preferences